IMPORTANCE Data on neurologic manifestations of fibromuscular dysplasia (FMD) are rare, and current knowledge remains limited.
F ibromuscular dysplasia (FMD) is an idiopathic, noninflammatory, nonatherosclerotic vascular disease of small to medium-sized arteries. 1, 2 In patients with FMD, the frequency of involvement of cervical (carotid and vertebral) and intracranial arteries is higher than previously thought and as common as those of the renal artery, but data on neurologic manifestations of FMD (or cerebrovascular FMD) remain rare. 1, 3, 4 Although it is generally considered a benign entity when discovered incidentally, cerebrovascular FMD can lead to potentially devastating cerebrovascular complications, including ischemic and hemorrhagic stroke. 3, 5, 6 Also, more than half of patients with cerebrovascular FMD have concomitant lesions in the renal artery, which implies that they are exposed to additional potentially severe renal complications, including hypertension, preeclampsia, and renal infarction. 1, 3, 4 This review summarizes the data on cerebrovascular FMD, along with a proposal for future research priorities.
Methods

Search Strategy
We searched studies indexed in PubMed using the MeSH term "fibromuscular dysplasia" or the text words "fibromuscular dysplasia" OR "fibromuscular hyperplasia" until December 31, 2017, with no language restrictions. We also identified additional studies by reviewing the bibliographies of relevant studies and searches of our personal files. We included articles describing at least 1 aspect of epidemiologic features, clinical characteristics, radiologic features, or outcomes of cervical or intracranial FMD and preferentially focused on studies published within the last 5 years and those including 15 patients or more. However, case reports or small case series describing interesting or noteworthy manifestations could be included. When publications involved overlapping study samples, only the largest and most recent study was included unless an article described new parameters or additional relevant data. The quality of evidence was rated according to the Oxford Centre for Evidence-Based Medicine levels of evidence. 7 
Results
We selected 68 studies of the 2788 titles identified through the PubMed search and 16 studies from hand searching, leading to the inclusion of 84 studies (eFigure 1 in the Supplement). Studies were mainly case series or retrospective studies with, therefore, a low quality of evidence (eTable 1 in the Supplement).
Classification and Diagnostic Criteria
The historical classification for FMD has focused on arterial wall involvement (medial, intimal, and adventitial subtypes). 1 However, in clinical practice, histologic specimens are rarely obtained, and diagnosis is most commonly based on radiologic findings. Therefore, the European consensus statement and the American Heart Association scientific statement on FMD have described a new classification based on angiographic appearance to replace the histopathologic classification (Table) .
1,2,8
Imaging High-level evidence data on imaging modalities for the diagnosis of cerebrovascular FMD are lacking, and no imaging modality can be recommended rather than another. Digital subtraction arteriography remains the gold standard for diagnosis of FMD owing to its higher sensitivity than computed tomography-angiography or magnetic resonance angiography ( Figure 1 and Figure 2 ; eFigures 2 and 3intheSupplement). 2, 9, 10 However, because of the risk of iatrogenic dissection with conventional arteriography (which may be higher in patients with FMD than in the general population), its use is typically restricted to severe cases of FMD requiring endovascular management while computed tomography-angiography or contrast-enhanced magnetic resonance angiography are commonly used as the initial imaging modality in most centers. Duplex ultrasonography may be used to diagnose and monitor patients with FMD involving the extracranial carotid arteries, but it is less accurate than computed tomography-angiography or magnetic resonance angiography ( Figure 3) 1,4-6 and inadequate for the assessment of vertebral or intracranial arteries. 11 Preferred techniques for each imaging modality are described in the eAppendix in the Supplement. Fibromuscular dysplasia occurs primarily in the cervical portion of the carotid and vertebral arteries, while intracranial FMD is rare, usually extending from extracranial FMD or as the predominant location of FMD subtypes in children. 5 Cerebrovascular FMD typically involves the middle and distal portions of the internal carotid artery and the V3-V4 segment of vertebral arteries at the level of the C1 and C2 vertebrae, areas that are usually spared by atherosclerosis.
Epidemiologic Characteristics
As in patients with renal FMD, cerebrovascular FMD is much more common in women and typically becomes symptomatic in the fifth decade (eTable 2 in the Supplement). There is typically no family history of FMD, with less than 5% of patients reporting an affected family member. [3] [4] [5] The role of hormonal factors in the development of FMD remains uncertain, and case-control studies have found no association between FMD and gravidity or exposure to exogenous hormones. 1 Although smoking has been reported to be associated with renal FMD, 1 no similar data exist for cerebrovascular FMD. 12 However, smoking and hormonal factors are associated with aneurysm growth and may therefore influence the risk of stroke in patients with FMD. 8, 13 The prevalence of cerebrovascular FMD in the general population is unknown. Only 0.02% of consecutive autopsies performed at the Mayo Clinic during a period of 25 years detected FMD of the
Key Points
Question What are the neurologic manifestations of fibromuscular dysplasia?
Findings This systematic review describes the epidemiologic characteristics, clinical and radiologic manifestations, prognosis, and management of fibromuscular dysplasia involving the cervical or intracranial arteries.
Meaning Cerebrovascular fibromuscular dysplasia is now considered as frequent as renal fibromuscular dysplasia, and longitudinal, international cohort studies with outcomes and genetic sequencing are needed to further understand its clinical course and enable the development of evidence-based treatments.
internal carotid artery.
14 Several studies suggest that the frequency of involvement of a cervical artery is now as frequent as that of the renal artery. 3, 15 Cerebrovascular FMD affects the carotid artery (often bilaterally) in 95% of cases and the vertebral artery (usually with co-involvement of the carotid artery) in 60% to 85% of cases. 5 Also, multiple locations, especially in the multifocal form but not limited to that form, are considered more common than previously thought. In the US Registry for Fibromuscular Dysplasia, involvement of the renal artery was reported in 64% of patients with cervical FMD, while cervical FMD lesions were found in 65% of patients with renal artery FMD. 3 In the ARCADIA (Assessment of Renal and Cervical Artery Dysplasia) Registry, where assessment for multisite involvement was systematic, the prevalence of multisite locations was 48% in patients with FMD and 54% in those with cerebrovascular presentation. Also, among patients with FMD with a cerebrovascular presentation, the prevalence of renal artery FMD involvement was 3 times higher among those with a history of hypertension, suggesting that a history of hypertension could help to identify patients who may benefit from screening for renal FMD. 4 Data on the prevalence of involvement of other arterial beds (eg, brachial, celiac, iliac, and coronary) in patients with cerebrovascular FMD are scarce. 1, 15 Although FMD is rarely reported in the coronary arteries, 16 a strong association between FMD and spontaneous coronary artery dissection has been identified, with a high prevalence of extracoronary FMD lesions in patients with spontaneous coronary artery dissection. 17 In a large series of patients with spontaneous coronary artery dissection (N = 168), cervical FMD was detected in 52% of the patients and intracranial aneurysms were detected in 14% of the patients. 18 In patients with cerebrovascular FMD, although the prevalence of spontaneous coronary artery dissection is very low, silent coronary lesions may exist; however, the cost-effectiveness of screening for associated coronary artery disease is unknown, and screening is not recommended.
Genetic Risk
Heritability estimates of FMD are challenging owing to the frequency of an asymptomatic phenotype and the lack of accurate characterization in family histories. Several candidate gene studies of FMD have had negative results or have had positive results only in isolated case reports (eTable 3 in the Supplement), 8 and genome- This same risk allele has previously been associated with migraine and cervical artery dissection and has recently been found to regulate the expression of endothelin-1 with known physiologic effects on the systemic vasculature. 23 
Presenting Manifestations
Although cerebrovascular FMD is frequently asymptomatic and diagnosed incidentally via results of imaging performed for other indications, the most common presenting symptoms are headaches and pulsatile tinnitus. 3, 4 Compared with the general population, patients with FMD have a high prevalence of associated cervical (carotid or vertebral) artery dissection and intracranial saccular aneurysm. 5, 24 The main complications of cerebrovascular FMD are transient ischemic attack (TIA) or ischemic stroke, followed by subarachnoid hemorrhage and intracerebral hemorrhage (eTable 2 in the Supplement). Headaches are reported by 70% of patients with cerebrovascular FMD, with 30% experiencing migraine. 3, 4, 15 Despite the high coprevalence of headaches and migraine with cerebrovascular FMD, the underlying pathophysiologic features remain unclear. Possible mechanisms include alterations in cerebrovascular flow (eg, labile hypertension, hyperperfusion, or hypoperfusion), neurovascular dysregulation or dysautonomia, structural injury (eg, dissection or microtrauma), or heightened sensitivity to pain. 25 Carotid bruit (the most common presenting sign of cervical FMD) and/or pulsatile tinnitus, often described by patients as an auditory "whooshing," are observed in up to 40% of patients with cervical FMD. 3 Less frequently reported symptoms include neck pain or carotidynia, blurry vision, and dizziness, with the latter being described mostly as lightheadedness or presyncope as opposed to vertigo. These nonspecific symptoms may represent manifestations of fluctuating blood pressure, persistent migraine aura, or dysautonomia secondary to neurovascular disruption in the vessel wall. In rare cases, lightheadedness may be due to cerebral hypoperfusion related to severe multivessel cerebrovascular FMD. Recent data from the US Registry for Fibromuscular Dysplasia have shown that the prevalence of carotid artery dissections in all patients with FMD is estimated to be 16% and the prevalence of vertebral artery dissections is estimated to be 5%. 3 Among patients with FMD who experience a dissection, the carotid artery is the most frequently involved (64%), followed by the vertebral artery (21%), and the prevalence of multiple cervical dissections is high (up to 37%). Among patients with FMD with a neurologic presentation in the ARCADIA registry, the prevalence of cervical dissection was 27%. 4 Concomitantly, studies of individuals with cervical artery dissection report that the prevalence of cervical FMD may be as high as 15%to20% 8, 26 and is increased in the presence of multiple cervical dissections. 27 Cervical dissection is seen most often in the middle to distal segments of the extracranial internal carotid artery and vertebral arteries, where traction on the arteries is maximal. Extension and lateral rotation of the head and neck enhance stretching of the cervical arteries, which may play a role in the association between FMD and cervical dissection. Whether these mechanical factors are involved in the possible causes of cerebrovascular FMD remains speculative. 5 Intracranial saccular aneurysms are mainly unruptured and diagnosed incidentally on results of imaging rather than discovered after rupture. A meta-analysis of more than 500 patients with cerebrovascular FMD reported a prevalence of unruptured intracranial aneurysm of 7%, which was higher than that expected in the general population (<5%). 28 In the US Registry for Fibromuscular Dysplasia, 3 13% of women with FMD had at least 1 intracranial aneurysm and 4% had more than 1 intracranial aneurysm. A total of 29% of these aneurysms were 5 mm or larger, which is the threshold usually considered to classify intracranial aneurysms with a higher risk of rupture. 29 Also, there was no difference in the prevalence of intracranial aneurysms between patients with renal and cervical FMD. 30 Whether the risk of rupture of intracranial aneurysm is higher in patients with FMD than in the general population (<1% per year) remains uncertain. 
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Transient ischemic attack or ischemic stroke in patients with FMD can result from different mechanisms: hypoperfusion from cervical or intracranial arterial stenosis or occlusion (hemodynamic mechanism), emboli from a thrombosis in the area of a stenosis or dilation, or via thrombosis of small, perforating arteries, due to chronic hypertension secondary to the coexistence of renal FMD (lacunar stroke). However, TIA and ischemic stroke seem to occur mainly in the presence of associated cervical artery dissection due to arteryto-artery thromboembolism or cerebral hypoperfusion. In the US Registry for Fibromuscular Dysplasia, 10% of patients with FMD presented with ischemic stroke and 20% with TIA. 3 Intracerebral hemorrhage is rare in patients with FMD but can occur in the presence of hypertensive microangiopathy or from the rupture of an intracranial aneurysm or dissection. 5 Subarachnoid hemorrhage results mainly from the rupture of an intracranial aneurysm and less commonly from a dissecting vertebral artery into the intracranial segment. 5 The prevalence of subarachnoid hemorrhage is estimated to be 3% in all patients with FMD and 20% among those who present with acute neurologic manifestations. 4 
Specific Subtypes of FMD Purely Intracranial FMD
Although intracranial FMD most often corresponds to the extension of extracranial cervical FMD, 5 isolated intracranial FMD with a typical "string of beads" angiographic appearance in the basilar artery, distal internal carotid artery, and middle cerebral artery has also been reported. 5 Purely intracranial FMD seems to be rare and is more frequent in children than in adults. 5, 31 In addition, autopsy reports of patients with fatal intracranial artery dissection or aneurysmal subarachnoid hemorrhage have shown histologic evidence of FMD. 5, 32 Histologic evidence of FMD has also been reported in fusiform or dolichoectactic intracranial artery, 33,34 moyamoya syndrome, and carotid-cavernous fistula. 5 While FMD of extracranial arteries typically involves the medial layer of the vessel wall, intracranial FMD predominantly involves the intima, suggesting a genotype-phenotype variation by anatomical location in the cerebrovascular vasculature.
Children
A recent study combining a large series of new cases with the existing literature (totaling 81 cases) showed that cerebrovascular FMD in children (age, <18 years) differs from adults in clinical and histologic characterisics. 31, 35 Both sexes are equally affected, and most cases are diagnosed early in childhood (mean age, 7 years), with onethird being diagnosed in the first year of life. Focal FMD with pathologic characteristics of intimal fibroplasia seems to be the predominant form, while the more typical adult appearance of multifocal FMD (medial fibroplasia) is estimated to be very rare. 31 Associated moyamoya syndrome and intracranial aneurysms have also been reported. Systemic FMD occurred frequently in children, with 63% having renal FMD and 72% having an additional arterial bed involvement. Ischemic stroke appears to be the predominant presentation (63% of cases), mainly due to intracranial stenosis, and affects multiple territories (40%). The outcome remains poor, with a high annual rate of recurrent stroke (10%) and death (13%). Carotid Bulb Diaphragm FMD An entity called the arterial diaphragm or web was reported to share similar histologic findings with FMD, with intimal fibroplasia without atheromatous or inflammatory lesions being described in almost all cases treated by surgery. 5, 36, 37 Several authors estimate that this entity could be the predominant form of FMD in black populations and have classified it as atypical FMD. 38 Arterial diaphragms are thin translucent endoluminal webs located in the carotid artery (especially in the posterolateral side of the carotid bulb) or vertebral artery (V3 segment or ostium) and correspond to a linear defect seen on angiography that do not change or disappear after modification of the patient's head position ( Figure 4) . [39] [40] [41] Since its first description of carotid FMD, 42 more than 50 cases with carotid bulb diaphragm FMD have been reported. Diaphragms typically affect middle-aged adults, predominantly women, of African or Afro-Caribbean ethnicity, with no atherosclerotic risk factors. 36 The main clinical presentations are TIA or ischemic stroke ipsilateral to the diaphragm, and a strong association between carotid bulb diaphragm FMD and ischemic stroke has been reported in a population-based case-control study. 38 Cerebral ischemia is estimated to be mediated by an embolic mechanism because of stasis upstream to the web or within an associated aneurysmal bulb or from focal dissection. In several cases, carotid diaphragm FMD was associated with the presence of an aneurysmal bulb (sometimes called megabulb), 37, 44 which may also contribute to the risk of cerebral thromboembolism.
In the presence of TIA or ischemic stroke, the rate of recurrent ischemic events in the same territory seems particularly high in patients receiving antiplatelet therapy, up to 30% at 1 year in the largest cohort. 36 In cases of recurrent ischemic events despite medical management, diaphragm exclusion with endarterectomy 36 or stenting 43 has been proposed. The largest cohorts of patients undergoing diaphragm exclusion by either method (N = 25) reported no recurrences after a follow-up of 1 to 2 years.
Management of FMD
In the absence of randomized trials in patients with cerebrovascular FMD, current medical and interventional strategies rely on observational data and expert opinion. Because of the high prevalence of aneurysms and dissections in other arterial beds (including renal and aortic branch arteries), patients diagnosed with cerebrovascular FMD should undergo head-to-pelvic vascular imaging.
Cerebrovascular FMD Without Stroke Complications
In the presence of FMD without stroke complications, including associated asymptomatic cervical artery dissection, daily low-dose aspirin (75-100 mg/d) is a reasonable choice to prevent thromboembolic complications, with no evidence to suggest that alternative antiplatelet agents or combination therapy offers additional benefit for primary stroke prevention. 1 Because of the prevalent involvement of other arterial beds, a multidisciplinary approach should be used. 2 Hypertension, which is commonly observed in patients with FMD either due to essential or associated renal artery involvement, needs to be controlled. Data comparing antihypertensive therapies in patients with FMD and hypertension are lacking, and uncertainties remain about which drugs work best in this population. Current guidelines on hypertension should therefore be followed for these patients. 45 In view of the high prevalence of unruptured intracranial aneurysm, patients with FMD should also be encouraged to quit smoking, but no data are available in the literature to recommend one method to quit smoking compared with any others. Observational studies of patients with cervical artery dissection suggest an inverse association between dyslipidemia and risk of dissection, in contrast with patients with atherosclerotic disease. 46 Therefore, statins are not recommended for patients with FMD unless to treat coprevalent dyslipidemia or atherosclerotic disease. Surgical or endovascular therapy is not recommended for patients with asymptomatic carotid FMD, regardless of the severity of stenosis. 47 Patients should likely avoid chiropractic spinal manipulation and other activities involving rapid hyperextension or lateral rotation of the neck owing to the theoretical increased risk of cervical dissection. 48 
Migraine and Pulsatile Tinnitus
Although migraine is a common and potentially disabling disorder, to our knowledge, no studies have assessed interventions for migraine in patients with FMD. Whether typical treatment response differs in patients with FMD or whether certain classes of pharmacotherapy may have specific effects in FMD-related migraine remains unknown. Similar medical management as in the general population is recommended, although abortive triptan therapy or other sympathomimetic agents should be used with caution owing to the potential for vasoconstriction. 25 Some studies suggest that patients with incapacitating pulsatile tinnitus might benefit from psychological therapies, 49 although none of these studies focused on patients with FMD.
Unruptured Intracranial Aneurysm
In the shortage of data on predictors of rupture of intracranial aneurysm in patients with FMD, similar management as in the general population should be proposed. Securing an unruptured intracranial aneurysm (by surgical clipping or endovascular coiling) might be discussed in the presence of risk factors for rupture. 29 Concern has been raised about the use of antiplatelet therapy in patients with FMD because of the high prevalence of intracranial aneurysm. There are insufficient data to establish an association between use of antiplatelet agents and risk of rupture of intracranial aneurysm. 29 The use of antiplatelet therapy seems reasonable in patients with FMD who have a small, unruptured intracranial aneurysm. Patients with unruptured intracranial aneurysms who did not undergo an intervention are often monitored with noninvasive imaging, but predictors of aneurysm growth remain unclear and the optimal frequency of follow-up is unknown. 50 
Cerebrovascular FMD With Stroke Complications
In patients with FMD who have a TIA or ischemic stroke due to arterial stenosis or dissection, management should be similar to that of patients without FMD. 51 In the acute phase, intravenous thrombolysis and/or mechanical thrombectomy are recommended in eligible patients, while an antithrombotic agent is to be prescribed in patients who are not eligible for intravenous thrombolysis. 26, 52 Secondary prevention of TIA and ischemic stroke should be tailored to the underlying stroke mechanism. Long-term antithrombotic therapy is recommended, but statins are not indicated in the absence of dyslipidemia or vascular atherosclerotic disease. 53 Endovascular therapy (eg, carotid angioplasty with or without stenting) is typically restricted to patients with persistent cerebrovascular ischemia despite optimal medical therapy, 52, 54, 55 while dissecting aneurysms (ie, pseudoaneurysms) are at low risk of ischemic events or rupture and rarely require endovascular treatment. 56, 57 If an endovascular intervention is indicated, careful attention should be made to avoid iatrogenic vascular injury during groin access or guided placement of a catheter. However, whether cerebrovascular FMD increases the risk of iatrogenic dissection or poststenting pseudoaneurysm development is unknown. The management of intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage in patients with FMD does not differ from the management in those without FMD. 58, 59 There is limited evidence for endovascular or surgical treatment in cases of intracranial dissection 60 or moyamoya syndrome in the setting of cerebrovascular FMD. 61 
Box. Proposal for Future Research Priorities in Cerebrovascular Fibromuscular Dysplasia (FMD)
1. Better determine the natural history of cerebrovascular FMD, identify risk factors for cerebrovascular complications, and address optimal symptomatic and preventive management in cerebrovascular FMD. Also, more research is needed to riskstratify asymptomatic and benign FMD phenotypes from more severe types with more disabling symptoms or higher risk for stroke, associated cervical artery dissection, or intracranial aneurysm formation. Prospective randomized clinical trials are warranted in cerebrovascular FMD but limited by the relatively small numbers of cases at single centers. Therefore, multicenter trials or expanded registries remain a top research priority. Apart from the US and the European registries, others have been implemented in Argentina, Australia, China, Japan, and Tunisia, and strategies to raise awareness of the existence of these registries should be facilitated to help increase our collective knowledge. The French research programs ARCADIA (Assessment of Renal and Cervical Artery Dysplasia) and PROFILE (Progression of Fibromuscular Lesions) are currently addressing the coprevalence of cerebrovascular and renal FMD and the risk of clinical or radiologic progression in a cohort of about 500 patients. 4 2. Provide further insight, beyond the PHACTR1 (GenBank 221692) locus, into the genetics and pathophysiology of FMD and associated cerebrovascular phenotypes, including migraine, cervical artery dissection, and intracranial aneurysm. We also need better pathophysiological understanding of the mechanism of disease mediated by the PHACTR1 locus on downstream endothelin expression and physiology in the arterial wall. Genetic data collection should be more promoted among clinicians and patients to allow further sequencing studies. 3. Characterize the mechanisms of migraine and/or headache in cervical FMD as well as identify which treatment strategies are safe and likely to be the most beneficial. 4. Elucidate whether there is an inflammatory or hormonal role in the development, progression, and management of cervicocephalic FMD. 5. Determine additional research priorities that are important to patients with cerebrovascular FMD using patient advocacy groups. Prognosis Given the lack of high-quality population-based data, the risk of incident and recurrent stroke in patients with cerebrovascular FMD remains uncertain. Longitudinal studies of patients with cerebrovascular FMD (most of whom presented with TIA or ischemic stroke) reported a risk of TIA or ischemic stroke during follow-up between 0.6% and 3.7% per year and a risk of intracerebral hemorrhage of less than 1% per year 6,62-67 (eTable 4 in the Supplement). Risk of progression of FMD in cervical or intracranial arteries was estimated to be less than 1% per year, but no systematic imaging screening was performed in these studies. 6, 65, 67 Looking at the most recent (>2015) studies of patients with cervical FMD totaling approximately 100 patients (53% with previous TIA or stroke), the risk of all stroke or TIA during follow-up was less than 0.5% per year. 6, 67 All patients but 1
with a follow-up event had a previous stroke, and none had a progression of FMD in the previously affected artery. Data from the US Registry for Fibromuscular Dysplasia suggest that TIA and ischemic stroke occur mainly in patients with an associated cervical dissection. 3 In the absence of stroke complications, the prognosis of isolated cerebrovascular FMD appears relatively favorable, although cerebrovascular events have been reported in previously unaffected arteries, but data on risk factors for progression of FMD are lacking. Computed tomography-angiography (CTA) The preferred technique for CTA includes contrast bolus injection with bolus-tracking acquisition that allows for detection of luminal defects and arterial wall dysplasia. 1 Post-processing is a helpful tool in the diagnosis of fibromuscular dysplasia (FMD) involving the cervico-encephalic arteries, including volume rendering, maximum intensity projection, and multi planar reconstruction.
Magnetic resonance angiography (MRA)
Several acquisition techniques and protocols for MRA (such as "time-of-flight", contrast enhanced time-offlight, or 3D contrast enhanced fast spin echo) are available but none of these sequences have been compared to one another for the diagnosis of cerebrovascular FMD. However, dynamic contrast enhancement is recommended to reduce artifact due to turbulence and flow modification.
1,2 Like CTA, post-processing tools of MRA may further assist in the diagnosis for mild or focal forms of cervico-cephalic FMD (efigure 2).
Duplex ultrasound
Duplex ultrasound may be used to diagnose and monitor patients with FMD involving the extracranial carotid arteries but is less accurate than CTA or MRA (Figure 3) . Ultrasound is also inadequate for the assessment of vertebral or intracranial arteries. 3 The string of beads appearance, (visualised by multiple areas of focal hyperechoic thickening of the arterial wall alternating with thin dilated areas), is not commonly seen on ultrasound. 
